KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Long-Term Investments (2016 - 2025)

Merck (MRK) has disclosed Long-Term Investments for 17 consecutive years, with $956.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 106.48% to $956.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $956.0 million through Dec 2025, up 106.48% year-over-year, with the annual reading at $956.0 million for FY2025, 106.48% up from the prior year.
  • Long-Term Investments for Q4 2025 was $956.0 million at Merck, down from $1.1 billion in the prior quarter.
  • The five-year high for Long-Term Investments was $1.3 billion in Q3 2023, with the low at $238.0 million in Q2 2022.
  • Average Long-Term Investments over 5 years is $590.8 million, with a median of $503.5 million recorded in 2021.
  • The sharpest move saw Long-Term Investments soared 1021.21% in 2021, then plummeted 75.17% in 2023.
  • Over 5 years, Long-Term Investments stood at $370.0 million in 2021, then surged by 174.32% to $1.0 billion in 2022, then tumbled by 75.17% to $252.0 million in 2023, then soared by 83.73% to $463.0 million in 2024, then surged by 106.48% to $956.0 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $956.0 million, $1.1 billion, and $774.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.